Javelin Pharmaceuticals, Inc. (JAV)
The Company is engaged in the research, development and commercialization of innovative treatments for the relief of moderate to severe pain.
Recs
bg11235
(89.95)
Submitted: 10/19/2009 12:53:28 PM :
Start Price:
$1.66
JAV Score:
-13.99
One more on BravoBevo's coattails.
Recs
expatriot08
(83.77)
Submitted: 10/13/2009 12:24:46 PM :
Start Price:
$1.72
JAV Score:
-19.41
Low market Cap pharma. Getting in now and hoping for good news in October conference call. Fingers crossed for a partnership and not not shares dilution.
Recs
08PortfolioModel
(< 20)
Submitted: 10/7/2009 10:40:50 PM :
Start Price:
$1.65
JAV Score:
-14.38
Current 1.76, Oct 7 09. Limit 1.66
Recs
Pennyperson
(< 20)
Submitted: 9/21/2009 4:37:15 PM :
Start Price:
$2.04
JAV Score:
-32.94
Company is in a great position to be acquired due to its relatively low market cap compared to its large cap peers. With low cash position, and three late-staged drugs- this equals to million(s) of dollars in revenue potential.
The pain management drugs have the attention of the military. They did have a recent sit back on the mixed Phase III data for its Ereska drug candidate to treat post-operative pain. However, they will reevaluate and continue to test it further.
JAV did beat earnings estimates in the last reported quarter and Mr. Zack is ranking this a Strong Buy with Reuters ranking it Outperform.
For around $2, it appears to be an opportunity to double your investment by mid 2010. However, with an acquisition - you could see it fly to $5 or $6 or an extreme $7
Recs
BigFatBEAR
(99.16)
Submitted: 9/1/2009 2:19:54 AM :
Start Price:
$1.76
JAV Score:
-27.39
Bravo, Port, vanamonde, and zzlangerhanz are all green-thumbed, as is a guy who really knows his biotechs over on kaching.com...
http://www.kaching.com/kaching#portfolio/6282/research/JAV/long
That's an impressive pitch, and an impressive array of knowledgeable backers.
Recs
jamespeer
(94.76)
Submitted: 8/26/2009 4:57:13 AM :
Start Price:
$1.86
JAV Score:
-30.58
Healthcare sector still has some way to go, I think the sell off on this sock has been overdone recently. This company is continuing to generate strong revenvues...
Recs
nibs61
(70.00)
Submitted: 7/27/2009 7:06:35 PM :
Start Price:
$1.99
JAV Score:
-41.72
I have owned this stock since March and been waiting for there Drugs to get ready for FDA aapproval. They are also a buyout opportunity for some bigger Pharm companies. The stock didn't move for 4 months and all of a sudden it is climbing everyday. Something is coming soon so don't wait. They are also a good long term buy if they can get FDA approval and then really start turning out some new drugs. Also Dodd's wife is on their board of directors ???
Recs
tthwebster
(25.50)
Submitted: 1/31/2009 12:30:58 PM :
Start Price:
$2.41
JAV Score:
-34.18
Why would any hospital utilize Dyloject as an injectable pain medication, when it would replace Voltarol which is an ingestible product? Because Dyloject administrative cost are about 20% for the like application. Since the application of this product is for "Post Operative Pain", there is little advantage to an ingestible product. Recent news in European countries where Dyloject is already in market proves the acceptance of the product as a replacement for other costly methods of post operative pain medication. With the development of Rylomin in Phase III (intranasal morphine) for acute severe pain and Ereska also in Phase III (intranasal ketamine) for acute moderate to severe pain, I am two to four years bullish for Javelin.
Recs
biovestor
(< 20)
Submitted: 6/30/2008 10:03:28 AM :
Start Price:
$2.50
JAV Score:
-32.17
A micro-cap specialty pharma focused on pain and unique drug delivery technology, JAV languishes near its lows despite EU approval/launch of Dyloject, two more drugs in pipeline, and work on US approval for Dyloject serving as future catalysts.
Recs
JohnnyiPhone
(< 20)
Submitted: 6/11/2008 11:25:29 AM :
Start Price:
$2.92
JAV Score:
-36.17
Penny stock ready!
Recs
ESTES27112
(< 20)
Submitted: 5/16/2008 5:01:57 PM :
Start Price:
$3.20
JAV Score:
-35.57
This stock has been bludgeoned, but has now found and bottom and with 3 drugs in phase 3, this company could see profits within 2 years.
Recs
bluedome
(67.72)
Submitted: 5/14/2008 9:06:55 PM :
Start Price:
$3.29
JAV Score:
-37.74
Technical, going with the bounce and
continuation of today's trend
Recs
ethanbryson
(49.69)
Submitted: 5/9/2008 10:35:27 AM :
Start Price:
$2.65
JAV Score:
-27.17
The market for pain management drugs is enormous and continues to grow. Each of the three products (one of which is already approved and on the market in Europe) this company is bringing to market is a reformulation of an existing drug with a proven safety record. Though I believe biotech stocks are always a gamble, I see very little downside and considerable upside for this stock over the next few years.
Recs
MB001
(< 20)
Submitted: 4/24/2008 6:27:10 PM :
Start Price:
$2.77
JAV Score:
-30.51
Get ready for this one to take off!!!!!!!!!!!!!!! Great pipe line new mgm and new marketing dept plus new board members that get it. Great pipeline of taking existing drugs and finding new uses and the pain pump when approved will set this stock soaring. Predict it to go 9 or 10 in the next year watch this one!!!!!
Recs
Deadeye111
(< 20)
Submitted: 4/20/2008 8:24:36 PM :
Start Price:
$2.91
JAV Score:
-33.68
Martin J. Driscoll new COE will make a difference
Recs
Newf100
(43.59)
Submitted: 4/19/2008 11:32:04 AM :
Start Price:
$2.91
JAV Score:
-33.68
Just a gut feeling
It could be just gas
Recs
fooluser17
(89.99)
Submitted: 1/10/2008 1:54:40 PM :
Start Price:
$3.63
JAV Score:
-42.84
Usually I stay away from pharmaceuticals, but with Fortis giving it the green light and with the drugs they have ready to come out, plus the stock price (gives "nowhere to go but up" a whole new meaning)...seems like a safe bet without much $ to lose.
Recs
axxl38
(37.56)
Submitted: 12/13/2007 7:17:08 PM :
Start Price:
$4.40
JAV Score:
-45.93
Great drugs in the pipeline.This company will start to make money and so will I.
Recs
icemeta
(< 20)
Submitted: 12/3/2007 9:07:55 PM :
Start Price:
$3.79
JAV Score:
-41.31
The lead drug is on fast track & the Army wants it.
Recs
martialman7
(< 20)
Submitted: 11/30/2007 3:49:39 PM :
Start Price:
$4.07
JAV Score:
-43.32
All the news from Javelin has been exceptional. Their pain drug Dyloject has been approved for sale in UK and should be approved for all EC shortly. They have two other drugs in final stage.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 37 1 2 Next »